Garcinol, a polyisoprenylated
benzophenone, has been demonstrated to exert anti-
cancer effects in various
tumor cells. However, the effect of
garcinol on
cervical cancer (CC) cell progression and the related molecular mechanism remains poorly understood. Accumulating evidence has verified that downregualtion of
T-cadherin is closely associated with
tumorigenesis, suggesting that
T-cadherin might be a potential therapeutic target for
cancer treatment. In the present study, Hela and SiHa cells were treated with different concentrations of
garcinol (0, 5, 10, and 25 u M), and
T-cadherin siRNA was synthesized and transfected into Hela and SiHa cells combined with
garcinol (25 u M) treatment. We found that
garcinol dose-dependently suppressed cell viability, colony formation, invasion, migration, cell cycle progression, and promoted cell apoptosis in CC cell lines, as well as inhibited
tumor growth in xenograft model. Importantly, our results showed that
garcinol treatment increased the expression of
T-cadherin both in vitro and in vivo, and knockdown of T-cahderin partially reversed
garcinol-induced inhibition of CC development via activating P13 K/AKT signaling pathway in CC cell lines. Thus, these findings demonstrated the
tumor suppressive function of
garcinol on CC progression, and emphasized that the
T-cadherin/P13 K/AKT was a potential mechanism involved in the antumor effects of
garcinol.